...
首页> 外文期刊>Molecules >Enhancement of Exposure and Reduction of Elimination for Paeoniflorin or Albiflorin via Co-Administration with Total Peony Glucosides and Hypoxic Pharmacokinetics Comparison
【24h】

Enhancement of Exposure and Reduction of Elimination for Paeoniflorin or Albiflorin via Co-Administration with Total Peony Glucosides and Hypoxic Pharmacokinetics Comparison

机译:通过与总牡丹糖苷合用和缺氧药代动力学比较,提高Pa药苷或白花苷的暴露量并减少消除

获取原文
获取原文并翻译 | 示例
           

摘要

There is evidence suggesting that herbal extracts demonstrate greater bioactivities than their isolated constituents at an equivalent dose. This phenomenon could be attributed to the absence of interacting substances present in the extracts. By measuring the pharmacokinetic parameters of paeoniflorin (PF) and albiflorin (AF) after being orally administered to rats in isolated form, in combination with each other and within total peony glucosides (TPG), respectively, the current study aimed to identify positive pharmacokinetic interactions between components of peony radix extracts. Moreover, the pharmacokinetic profiles of PF and AF under normoxia and hypoxia were also investigated and compared. In order to achieve these goals, a highly sensitive and reproducible ultra-peformance liquid chromatography-mass spectrometry (UPLC-MS) method was developed and validated for simultaneously quantitation of PF and AF in rat plasma. This study found that compared with that of single component (PF/AF), the exposure of PF in rat plasma after combination administration or TPG administration was significantly increased, meanwhile the elimination of PF/AF was remarkably reduced. It was also noticed that AUC and C-max of PF in hypoxia rats were significantly decreased compared with that of normaxia rats, suggesting that there was a decreased exposure of PF in rats under hypoxia. The current study, for the first time, revealed the pharmacokinetic interactions between PF/AF and other constitutes in TGP and the pharmacokinetic profiles of PF and AF under hypoxia. In view of the current findings, it could be supposed that the clinical performance of total peony glucosides would be better than that of single constitute (PF/AF). The outcomes of this animal study are expected to serve as a basis for development of clinical guidelines on total peony glucosides usage.
机译:有证据表明,在相同剂量下,草药提取物比其分离出的成分具有更高的生物活性。这种现象可以归因于提取物中不存在相互作用的物质。通过分别以单独形式,相互结合和分别在总牡丹糖苷(TPG)内对大鼠口服给药后测量measuring药苷(PF)和白花苷(AF)的药代动力学参数,本研究旨在确定阳性药代动力学相互作用之间的牡丹基提取物。此外,还研究和比较了常氧和低氧条件下PF和AF的药代动力学特征。为了实现这些目标,开发了一种高度灵敏且可重现的超高性能液相色谱-质谱(UPLC-MS)方法,并验证了该方法可同时定量大鼠血浆中的PF和AF。本研究发现,与单组分(PF / AF)相比,联合给药或TPG给药后大鼠血浆中PF的暴露显着增加,同时PF / AF的消除也明显减少。还注意到缺氧大鼠的PF的AUC和C-max显着低于正常大鼠,这表明缺氧大鼠的PF暴露减少。当前的研究首次揭示了缺氧条件下PF / AF与TGP中其他成分之间的药代动力学相互作用以及PF和AF的药代动力学特征。鉴于目前的发现,可以认为总牡丹苷的临床表现将优于单一成分(PF / AF)。这项动物研究的结果有望作为制定牡丹总苷使用临床指南的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号